Novel Device Promising in AD Despite Missed Primary Endpoint
Summary
A noninvasive audiovisual stimulation device for Alzheimer’s disease misses the primary endpoint in the phase 3 HOPE trial but shows an encouraging signal of benefit in mild disease.
Description from Medscape.
Who is covering this
-
Novel Device Promising in AD Despite Missed Primary Endpoint
A noninvasive audiovisual stimulation device for Alzheimer’s disease misses the primary endpoint in the phase 3 HOPE trial but shows an encouraging signal of benefit in mild disease.
Comments
Comments need JavaScript.